The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 2 , Page 512 , February 2010

Reply to the Editor

References 

  1. Bozzani A, Arici V, Odero A. What is the real risk of stent graft infection in the treatmental of aorta-bronchial fistulas?. J Thorac Cardiovasc Surg. 2010;139:511–512
  2. Hacker S, Langenberger H, Plank C, Gorlitzer M, Ehrlich M, Dolak W, et al. Management of aortobronchial fistula developing 27 years after open aortic surgery by means of endovascular stent grafting. J Thorac Cardiovasc Surg. 27 April 2009;[Epub ahead of print]
  3. Brunner M, Krenn C, Roth G, Moser B, Dworschak M, Jensen-Jarolim E, et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med. 2004;30:1468–1473Epub 2004 Feb 28
  4. Szerafin T, Niederpold T, Mangold A, Hoetzenecker K, Hacker S, Roth G, et al. Secretion of soluble ST2-possible explanation for systemic immunosuppression after heart surgery. Thorac Cardiovasc Surg. 2009;57:25–29

PII: S0022-5223(09)01285-9

doi: 10.1016/j.jtcvs.2009.09.049

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 2 , Page 512 , February 2010

Article Tools